Be a part of International Webinar on
Computer aided Drug Design

About:

Meetings International (Meetings Int.) is a worldwide leader in delivering top quality conferences, gatherings, workshops and symposia in every single significant field of science, technology and medicine. Since its origin, Meetings Int. has been related with national and global affiliations, corporations and elevated level people, dedicated to have world class conferences and events. Meetings Int. supports broad scope research and friend survey at a broad range of specialists around the world. The key strategic objective of Meetings Int. is to communicate science and medical research between academia, and industry. Through motivating sessions and huge amounts of networking, you will figure out how to be much more nervy and strong than you are presently and allowed to develop your mind, develop your business, and develop your primary concern. We can soothe you of the time and asset depleting components of the occasions that you intend to hold. From wanting to planning, through and through; we will be there to guarantee you take the awards for one more splendid program. We organize conferences world-wide. All major conferences of Meetings International are accredited with Continuing Professional Development (CPD), Continuing Education (CE), and Continuing Medical Education (CME) Credits.

 1. Structural based drug design

Structure-based drug design or direct drug design relies on knowledge of the three dimensional structure of the biological target obtained through methods such as x-ray crystallography or NMR spectroscopy. Alternatively various automated computational procedures may be used to suggest new drug candidates.

 2. Neural network in drug design

Artificial neural networks (ANNs) are often used “in silico” drug design for correlation, classification, and prediction of the activity of bioactive compounds and drug.

 3. Risks associated with new drug development:

Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes preclinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.

4. Rational drug design techniques

Rational drug design refers to the development of medications based on the study of the structures and functions of target molecules. The role of rational drug design, besides developing effective drugs, is to avoid having to wait for pure luck to design a new drug or to use a shotgun approach in drug design.